Evidence map›Paper›PMID 24696739›Full record

ReviewInternational journal of clinical and experimental pathology2014

Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor: a case report and review of the literature.

Chih-En Tseng, Chien-Han Chen, Shao-Jer Chen, Chen-Lin Chi

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chih-En TsengDepartment of Pathology, Buddhist Dalin Tzu Chi Hospital Chiayi, Taiwan ; School of Medicine, Tzu Chi University Hualien, Taiwan.
Chien-Han ChenDepartment of Obstetrics and Gynecology, Buddhist Dalin Tzu Chi Hospital Chiayi, Taiwan.
Shao-Jer ChenSchool of Medicine, Tzu Chi University Hualien, Taiwan ; Department of Medical Imaging, Buddhist Dalin Tzu Chi Hospital Chiayi, Taiwan.
Chen-Lin ChiDepartment of Pathology, Buddhist Dalin Tzu Chi Hospital Chiayi, Taiwan.
Buddhist Tzu Chi General Hospital · TWTzu Chi University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant mesonephric mixed tumor (MMMT), or mesonephric carcinosarcoma, is a rare tumor with malignant epithelial and mesenchymal components, and is found mostly in the uterine cervix. While diagnosed at the early stage in most cases, MMMT can have an aggressive course. The clinical significance of the presence of sarcomatous components remains unsettled. We report a case of MMMT of the uterine cervix in a patient who presented with tumor rupture, instead of the common presentation, vaginal bleeding. This unusual presentation has not been reported in the literature. It implies that MMMT may progress rapidly without any prodrome and pose a surgical emergency. Unlike most cervical adenocarcinomas, both mesonephric adenocarcinoma and MMMT are not related to human papilloma virus (HPV) infection. Because mesonephric neoplasms have a different etiology, their prevention, screening, and treatment should be further investigated. Thirteen cases of MMMT reported in the literature are also reviewed.

Indexed as

CarcinosarcomaComorbidityDiabetes MellitusFemaleHumansHypertensionMesonephromaMiddle AgedRuptureUterine Cervical Neoplasmsmalignant mesonephric mixed tumorMesonephric carcinosarcomaruptureuterine cervix

Identifiers

PMID24696739
PMCPMC3971330
OpenAlexW55511919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.